Hosted on MSN9h
Does Medicare pay for dementia care? Here’s what coverage you can expect for treatments and therapies
In July 2024, donanemab, sold under the brand name Kisunla, received FDA approval. It is also an intravenous medication and ...
The Herald-Standard9h
Cheers & Jeers
Kisunla is used to treat adults with early symptomatic Alzheimer’s disease, which includes mild cognitive impairment and mild dementia. “This is real progress,” said Dr. Joanne Pike, Alzheimer’s ...
health.wusf.usf.edu16h
New drug gives hope to Floridians affected by Alzheimer’s disease
The FDA approved donanemab, which will be sold under the brand name Kisunla. The new drug helps slow decline in Alzheimer's patients with mild cognitive impairment.
WLRN23h
New drug gives hope to South Floridians affected by Alzheimer’s
Called Donanemab, this treatment from Eli Lilly will be sold under its brand name, Kisunla, and works as an intravenous ...
360dx1d
Roche, Beckman Coulter Deals Put Alzpath at Center of Plasma P-Tau 217 Alzheimer's Testing Space
The company looks to tackle the Alzheimer's market by supplying global diagnostics firms with the antibodies needed for their tests in the space.
Fox 41d
New Alzheimer's infusion hits market, SWFL woman one of first to get it
The US Food and Drug Administration approved Donanemab, also called Kisunla. Tuesday's decision put the monoclonal antibody ...
FDA approves new Alzheimer's drug, Kisunla, offering hope to Pensacola patients
It's not a cure-- but it is a step in the right direction.This month-- a new medication for alzheimer's, called 'kinsul'a, ...
labiotech2d
Is tau protein the key to defeating Alzheimer’s? Asceneuron thinks so and raises $100 million to prove it
Leqembi is an intravenous monoclonal antibody that binds to amyloid-beta, facilitating its removal from the brain. Eli ...
MedCity News2d
Tau-Focused Asceneuron Adds $100M as Oral Alzheimer’s Drug Advances to Phase 2 Trial
Novo Holdings led Asceneuron’s $100 million Series C financing. The Merck Serono spinout’s lead program is an oral small molecule designed to prevent aggregation of tau protein in neurodegenerative ...
FierceBiotech3d
Novo Holdings, J&J-backed Asceneuron raises $100M to take Alzheimer's asset into phase 2
With the first wave of Alzheimer’s disease drugs reaching the market, investors continue to seek out the next big advance in ...
Knowridge3d
Why new Alzheimer’s drug is so expensive
The Food and Drug Administration (FDA) recently approved a new drug from Eli Lilly to treat Alzheimer’s disease. Called ...